A Patient with Sickle Cell Disease and Recurrent Venous Thromboembolism after Renal Transplantation

Simona Raso, Antonio Carroccio, Alessandra Giuliano, Giuseppina Calvaruso, Rosario Di Maggio

Risultato della ricerca: Articlepeer review

Abstract

Venous thromboembolism (VTE) is a life-threatening complication, specially in case of recurrence. The appropriate duration of anticoagulant treatment following the first event is crucial. Risk factors that increase the risk of recurrence of VTE are many, and include medications, kidneydisease, renal transplantation (RT), and a diagnosis of sickle cell disease (SCD). There are currently no guidelines that define the duration of anticoagulant therapy after the first event in a patient with RT. We report a case of recurring episodes of VTE after RT in a SCD patient. Our case suggests that the use of a long-term anticoagulant treatment may be recommended in patients with SCD and RT after the first event of VTE.
Lingua originaleEnglish
pagine (da-a)85-89
Numero di pagine5
RivistaThalassemia Reports
Volume12
Stato di pubblicazionePublished - 2022

Fingerprint

Entra nei temi di ricerca di 'A Patient with Sickle Cell Disease and Recurrent Venous Thromboembolism after Renal Transplantation'. Insieme formano una fingerprint unica.

Cita questo